Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01945424 · ClinicalTrials.gov registry record
Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 244
- Enrollment target
NCT01945424 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 244 participants.
The verdict
NCT01945424 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 244 participants
- Enrollment target
Study Summary
The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on vaccine exposures, pregnancy outcomes, and fetal and offspring outcomes.
Interventions
- BIOLOGICAL Quadrivalent Influenza Vaccine (QIV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2013-08-16 |
| Est. Completion | 2019-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01945424
The ClinicalTrials.gov registry entry for NCT01945424 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quadrivalent Influenza Vaccine (QIV) is the first listed.
NCT01945424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01945424 about?
NCT01945424 is a clinical study titled "Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry". The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on vaccine exposures, pregnancy outcomes, and fetal and offspring outcomes.
What is the current status of trial NCT01945424?
This trial is currently completed. The enrollment target is 244 participants. The study started on 2013-08-16. Estimated completion is 2019-09-15.
What interventions are being tested in trial NCT01945424?
The interventions under investigation include: Quadrivalent Influenza Vaccine (QIV) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01945424?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.